Gregory Adams
Company: Elucida Oncology Inc.
Job title: Chief Scientific Officer
Seminars:
Broadening Therapeutic Indications to Cancers with Lower Target Antigen Expression with C’Dot Drug Conjugates 4:15 pm
C’Dot Drug Conjugates (CDCs) are a platform technology that is associated with specific tumor targeting/low normal tissue exposure CDCs have the potential to target and kill tumors with lower antigen expression than is normally possible with ADCs Clinical efficacy and safety data will be presented from the safety/dose escalation study of ELU001Read more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day Two